Goldman Sachs Group »

Viking Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $21M 1.1M 18.61
2023-09-30 $6.6M 595k 11.07
2023-06-30 $11M 693k 16.21
2023-03-31 $15M 870k 16.65
2022-12-31 $749k 80k 9.40
2022-06-30 $166k 57k 2.89
2022-03-31 $781k 260k 3.00
2021-12-31 $399k 87k 4.59
2021-09-30 $883k 141k 6.28
2021-03-31 $310k 49k 6.32
2020-12-31 $441k 78k 5.67
2020-09-30 $3.6M 625k 5.83
2020-06-30 $4.2M 576k 7.22
2019-12-31 $1.1M 143k 8.02
2019-09-30 $656k 96k 6.87
2019-06-30 $244k 29k 8.33
2019-03-31 $647k 65k 9.92
2018-12-31 $1.7M 220k 7.69
2018-09-30 $1.8M 105k 17.42
2018-06-30 $1.1M 115k 9.49
2018-03-31 $924k 211k 4.37
2016-12-31 $35k 29k 1.20
2015-12-31 $44k 13k 3.43
2015-09-30 $107k 18k 5.86
2015-06-30 $169k 24k 7.13